Genetic Manipulation of Cryptosporidium parvum with CRISPR/Cas9.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2020
Historique:
entrez: 28 8 2019
pubmed: 28 8 2019
medline: 24 11 2020
Statut: ppublish

Résumé

Cryptosporidium parvum can be reliably genetically manipulated using CRISPR/Cas9-driven homologous repair coupled to in vivo propagation within immunodeficient mice. Recent modifications have simplified the initial protocol significantly. This chapter will guide through procedures for excystation, transfection, infection, collection, and purification of transgenic Cryptosporidium parvum.

Identifiants

pubmed: 31452165
doi: 10.1007/978-1-4939-9748-0_13
doi:

Substances chimiques

Luciferases EC 1.13.12.-
CRISPR-Associated Protein 9 EC 3.1.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

219-228

Subventions

Organisme : Wellcome Trust
ID : 203134/Z/16/Z
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : K99 AI137442
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI060546
Pays : United States

Auteurs

Adam Sateriale (A)

Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Mattie Pawlowic (M)

Wellcome Trust Centre for Anti-Infectives Research, University of Dundee, Dundee, UK.

Sumiti Vinayak (S)

Department of Pathobiology, College of Veterinary Medicine, University of Illinois Urbana-Champaign, Urbana, IL, USA.

Carrie Brooks (C)

Center for Tropical and Emerging and Global Diseases, University of Georgia, Athens, GA, USA.

Boris Striepen (B)

Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA. striepen@vet.upenn.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH